Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.605 USD | -2.23% | +23.13% | +86.44% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 325M |
---|---|---|---|---|---|
Net income 2024 * | -168M | Net income 2025 * | -193M | EV / Sales 2024 * | - |
Net cash position 2024 * | 208M | Net cash position 2025 * | 339M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.65
x | P/E ratio 2025 * |
-1.66
x | Employees | 80 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.79% |
Latest transcript on Ventyx Biosciences, Inc.
1 day | -2.23% | ||
1 week | +23.13% | ||
Current month | +23.13% | ||
1 month | -4.86% | ||
3 months | +107.43% | ||
6 months | +68.68% | ||
Current year | +86.44% |
Managers | Title | Age | Since |
---|---|---|---|
Raju Mohan
FOU | Founder | 68 | 18-10-31 |
Martin Auster
DFI | Director of Finance/CFO | 49 | 21-04-30 |
John Nuss
CTO | Chief Tech/Sci/R&D Officer | 65 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Somu Subramaniam
BRD | Director/Board Member | 69 | 18-10-31 |
Allison Hulme
BRD | Director/Board Member | 61 | 23-01-10 |
Sheila Gujrathi
CHM | Chairman | 53 | 21-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.17% | 2 M€ | -.--% | ||
0.09% | 0 M€ | 0.00% | - | |
0.05% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 4.605 | -2.23% | 342,916 |
24-05-06 | 4.71 | -2.89% | 433,777 |
24-05-03 | 4.85 | -1.22% | 853,274 |
24-05-02 | 4.91 | +4.91% | 1,909,345 |
24-05-01 | 4.68 | +25.13% | 2,275,846 |
Delayed Quote Nasdaq, May 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+86.44% | 325M | |
+10.44% | 107B | |
+0.82% | 106B | |
+7.37% | 23.47B | |
-13.89% | 21.9B | |
-6.64% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- VTYX Stock